Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Drägerwerk AG & Co. KGaA

DRWKFPNK
Healthcare
Medical - Devices
$111.00
$0.00(0.00%)
U.S. Market opens in 14h 45m

Drägerwerk AG & Co. KGaA Fundamental Analysis

Drägerwerk AG & Co. KGaA (DRWKF) shows weak financial fundamentals with a PE ratio of 14.55, profit margin of 3.54%, and ROE of 8.01%. The company generates $3.4B in annual revenue with weak year-over-year growth of -0.08%.

Key Strengths

PEG Ratio0.81
Current Ratio1.76

Areas of Concern

ROE8.01%
Operating Margin5.20%
We analyze DRWKF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 48.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
48.0/100

We analyze DRWKF's fundamental strength across five key dimensions:

Efficiency Score

Weak

DRWKF struggles to generate sufficient returns from assets.

ROA > 10%
3.98%

Valuation Score

Excellent

DRWKF trades at attractive valuation levels.

PE < 25
14.55
PEG Ratio < 2
0.81

Growth Score

Moderate

DRWKF shows steady but slowing expansion.

Revenue Growth > 5%
-0.08%
EPS Growth > 10%
12.80%

Financial Health Score

Excellent

DRWKF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.20
Current Ratio > 1
1.76

Profitability Score

Weak

DRWKF struggles to sustain strong margins.

ROE > 15%
8.01%
Net Margin ≥ 15%
3.54%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DRWKF Expensive or Cheap?

P/E Ratio

DRWKF trades at 14.55 times earnings. This suggests potential undervaluation.

14.55

PEG Ratio

When adjusting for growth, DRWKF's PEG of 0.81 indicates potential undervaluation.

0.81

Price to Book

The market values Drägerwerk AG & Co. KGaA at 1.16 times its book value. This may indicate undervaluation.

1.16

EV/EBITDA

Enterprise value stands at 5.88 times EBITDA. This is generally considered low.

5.88

How Well Does DRWKF Make Money?

Net Profit Margin

For every $100 in sales, Drägerwerk AG & Co. KGaA keeps $3.54 as profit after all expenses.

3.54%

Operating Margin

Core operations generate 5.20 in profit for every $100 in revenue, before interest and taxes.

5.20%

ROE

Management delivers $8.01 in profit for every $100 of shareholder equity.

8.01%

ROA

Drägerwerk AG & Co. KGaA generates $3.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.98%

Following the Money - Real Cash Generation

Operating Cash Flow

Drägerwerk AG & Co. KGaA generates limited operating cash flow of $203.32M, signaling weaker underlying cash strength.

$203.32M

Free Cash Flow

Drägerwerk AG & Co. KGaA produces free cash flow of $132.17M, offering steady but limited capital for shareholder returns and expansion.

$132.17M

FCF Per Share

Each share generates $7.05 in free cash annually.

$7.05

FCF Yield

DRWKF converts 7.48% of its market value into free cash.

7.48%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

14.55

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.81

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.16

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.52

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.20

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.76

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.08

vs 25 benchmark

ROA

Return on assets percentage

0.04

vs 25 benchmark

ROCE

Return on capital employed

0.09

vs 25 benchmark

How DRWKF Stacks Against Its Sector Peers

MetricDRWKF ValueSector AveragePerformance
P/E Ratio14.5529.45 Better (Cheaper)
ROE8.01%779.00% Weak
Net Margin3.54%-24930.00% (disorted) Weak
Debt/Equity0.200.26 Strong (Low Leverage)
Current Ratio1.764.65 Neutral
ROA3.98%-19333.00% (disorted) Weak

DRWKF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Drägerwerk AG & Co. KGaA's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

14.76%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

253.15%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-3.67%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ